New product launches – maximise your chance of success
September 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch
You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
Brazil delays excipient GMP deadline
September 6, 2012Manufacturing and Production ANVISA, Brazil, GMP
Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …
Hospira buys Indian antibiotic plant
September 6, 2012Manufacturing and Production Hospira, India
US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …
Double approval for Pfizer cancer drugs
September 6, 2012Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc
Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …
Merck KGaA cuts over 10% of German workforce
September 5, 2012Research and Development
Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …
Pharma welcomes Hunt to top health job
September 5, 2012Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform
The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …
Pfizer to develop phase II cancer vaccine
September 4, 2012Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine
Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
Valeant to buy dermatogy firm Medicis
September 4, 2012Sales and Marketing Valeant
Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …
Contract research news in brief
September 4, 2012Research and Development CRO, Charles River, WuXi
Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
Genzyme recalls drug on failed stability testing
September 4, 2012Manufacturing and Production Genzyme, Stability Testing, pharma recalls
Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …
Cash incentive for NHS digital info sharing
September 3, 2012NHS, digital
NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …
Cash incentive for NHS digital info sharing
September 3, 2012NHS, digital
NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …
Novartis cheered by COPD trial results
September 3, 2012Research and Development COPD, ERS, Novartis
One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …
The ex-CEO’s Job Blog – part 1
September 3, 2012Medical Communications David Barratt, Jobs, careers, pharma jobs, restructuring, the ex-CEO's job blog
I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …
New quad HIV pill passed by FDA
September 2, 2012Sales and Marketing FDA, Gilead, HIV, stribild
Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …
J&J buys into Genmab cancer drug
August 31, 2012Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma
Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …
ABPI worried by public ignorance about medicines
August 31, 2012Sales and Marketing ABPI, UK
People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …
Publicis creates new digital agency Razorfish Healthware
August 31, 2012Medical Communications Razorfish Healthware, advertising, digital, publicis
Two Publicis agencies, Razorfish Health and Publicis Healthware International are to be merged to create Razorfish Healthware, which will focus …
CPC Healthcare joins Indigenus network
August 31, 2012Medical Communications CPC Healthcare Communications, CementBloc, Indegenus, Indigenus
CPC Healthcare Communications, based in Toronto, Canada, has joined Indigenus, the global network of independent healthcare agencies.The Indigenus network spans …
Patient death halts BMS hep C trial
August 30, 2012Sales and Marketing BMS, HCV, hepatitis C
Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
